当前位置:首页 - 行情中心 - 福安药业(300194) - 财务分析 - 现金流量表

福安药业

(300194)

  

流通市值:37.94亿  总市值:46.64亿
流通股本:9.68亿   总股本:11.90亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金754,433,823.992,568,631,827.731,855,166,914.561,208,266,206.52
收到的税费返还1,132,310.2310,732,630.4812,075,819.0110,823,916.23
收到其他与经营活动有关的现金21,803,368.25106,114,773.283,018,948.5459,607,287.71
经营活动现金流入的平衡项目0000
经营活动现金流入小计777,369,502.472,685,479,231.411,950,261,682.111,278,697,410.46
购买商品、接受劳务支付的现金155,325,679.24733,630,263.05537,567,694.15373,817,341.84
支付给职工以及为职工支付的现金145,478,877.28433,146,029.14321,215,510.39226,141,453.53
支付的各项税费75,319,193.61209,015,471.81166,396,445.2120,999,260.56
支付其他与经营活动有关的现金246,672,173.2980,709,340.56757,228,311.09508,311,486.12
经营活动现金流出的平衡项目0000
经营活动现金流出小计622,795,923.332,356,501,104.561,782,407,960.831,229,269,542.05
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额154,573,579.14328,978,126.85167,853,721.2849,427,868.41
二、投资活动产生的现金流量:
收回投资收到的现金5,000,00054,000,80039,000,00018,000,000
取得投资收益收到的现金259,362.34641,890.76163,125.342,622.22
处置固定资产、无形资产和其他长期资产收回的现金净额130,020122,667,526.18,129,890.17,689,865.1
收到的其他与投资活动有关的现金10,000,0005,097,535.45,177,535.45,137,535.4
投资活动现金流入的平衡项目0000
投资活动现金流入小计15,389,382.34182,407,752.2652,470,550.830,870,022.72
购建固定资产、无形资产和其他长期资产支付的现金65,025,878.13215,679,559.75139,766,390.49105,077,228.98
投资支付的现金-50,350,00045,350,00032,350,000
支付其他与投资活动有关的现金46,407,70010,000,00010,063,00010,000,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计111,433,578.13276,029,559.75195,179,390.49147,427,228.98
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-96,044,195.79-93,621,807.49-142,708,839.69-116,557,206.26
三、筹资活动产生的现金流量:
取得借款收到的现金338,136,141.65848,080,000830,080,000758,080,000
收到其他与筹资活动有关的现金33,876.045,032,661.672,622,540.581,936,115.48
筹资活动现金流入平衡项目0000
筹资活动现金流入小计338,170,017.69853,112,661.67832,702,540.58760,016,115.48
偿还债务支付的现金430,820,000705,284,464605,784,364389,900,000
分配股利、利润或偿付利息支付的现金8,739,977.1893,981,544.6479,156,519.272,749,187.18
支付其他与筹资活动有关的现金215,870.927,592,933.22,594,571.1817,036,040.76
筹资活动现金流出平衡项目0000
筹资活动现金流出小计439,775,848.1806,858,941.84687,535,454.38479,685,227.94
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-101,605,830.4146,253,719.83145,167,086.2280,330,887.54
四、汇率变动对现金及现金等价物的影响303,504.6878,465.52730,460443,182.54
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-42,772,942.46282,488,504.71171,042,427.79213,644,732.23
加:期初现金及现金等价物余额936,543,376.57654,054,871.86654,054,871.86654,054,871.86
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额893,770,434.11936,543,376.57825,097,299.65867,699,604.09
补充资料:
净利润-234,408,732.4-163,990,782.21
资产减值准备-241,667,187.25-4,273,700.23
固定资产和投资性房地产折旧-150,833,665.78-69,881,705.57
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-150,833,665.78-69,881,705.57
无形资产摊销-57,534,348.42-16,475,090.24
长期待摊费用摊销-718,208.29-410,708.7
处置固定资产、无形资产和其他长期资产的损失--220,653,129.81--3,304,055.05
固定资产报废损失-1,349,774.91-254,807.97
公允价值变动损失--408,339.51--238,727.42
财务费用-24,730,875.71-13,879,550.01
投资损失--77,393,502.73--34,536,624.55
递延所得税-22,785,712.21-5,915,214.17
其中:递延所得税资产减少-36,050,809.71-5,599,507.67
递延所得税负债增加--13,265,097.5-315,706.5
存货的减少-9,200,808.16--73,675,044.85
经营性应收项目的减少-71,852,383.19--27,690,920.17
经营性应付项目的增加--193,145,165.76--86,513,172.05
其他-4,796,190.28--
现金的期末余额-936,543,376.57-867,699,604.09
减:现金的期初余额-654,054,871.86-654,054,871.86
公告日期2024-04-252024-04-252023-10-262023-08-30
审计意见(境内)标准无保留意见
TOP↑